Tobradex ST (tobramycin / dexamethasone ophthalmic suspension 0.3%/0.05%)

Tobradex ST (tobramycin/dexamethasone) Ophthalmic Suspension 0.3%/0.05% a combination antibiotic and steroid used to treat bacterial infections of the eyes.

Tobramycin Injection (tobramycin injection)

Tobrex (tobramycin ophthalmic ointment)

Tobrex (tobramycin ophthalmic ointment) is an antibiotic used to treat bacterial infections of the eyes. Tobrex is available in generic form.

Tonocard (tocainide hcl)

Tonocard (tocainide HCl) is an antiarrhythmic drug used to treat serious irregularity in heartbeat patterns. The brand name Tonocard is discontinued, but generic versions may be available.

Tofidence (tocilizumab-bavi injection)

Tofidence (tocilizumab-bavi) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs); patients 2 years of age and older with active polyarticular juvenile

Xeljanz (tofacitinib tablets)

Xeljanz (tofacitinib citrate) is a Janus kinase (JAK) inhibitor used to treat adults with moderate to severely active rheumatoid arthritis (RA) who have not responded well to methotrexate, or cannot tolerate it.

Tolinase (tolbutamide tablets)

Tolinase (tolazamide) is an oral diabetes medicine used together with diet and exercise to treat type 2 (non-insulin dependent) diabetes. Other diabetes medicines are sometimes used in combination with Tolinase if needed. The brand name Tolinase is discontinued but generic versions may be available.

Tolectin (tolmetin sodium)

Topamax (topiramate)

Topamax (topiramate) is an anticonvulsant prescribed for preventing epileptic seizures and migraine headaches. Topamax is available as a generic drug.

Trokendi XR (topiramate extended-release capsules)

Trokendi XR (topiramate) Extended-release is a sulfamate-substituted monosaccharide used as initial monotherapy in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures and adjunctive therapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures.